- Home
- RGNX vs SUPV Comparison
RGNX vs SUPV Comparison
Compare RGNX & SUPV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGNX
- SUPV
- Stock Information
- Founded
- RGNX 2008
- SUPV 1887
- Country
- RGNX United States
- SUPV Argentina
- Employees
- RGNX N/A
- SUPV N/A
- Industry
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- SUPV Commercial Banks
- Sector
- RGNX Health Care
- SUPV Finance
- Exchange
- RGNX Nasdaq
- SUPV Nasdaq
- Market Cap
- RGNX 451.1M
- SUPV 450.9M
- IPO Year
- RGNX 2015
- SUPV 2016
- Fundamental
- Price
- RGNX $12.50
- SUPV $5.55
- Analyst Decision
- RGNX Strong Buy
- SUPV Hold
- Analyst Count
- RGNX 8
- SUPV 3
- Target Price
- RGNX $28.50
- SUPV $17.00
- AVG Volume (30 Days)
- RGNX 525.7K
- SUPV 2.6M
- Earning Date
- RGNX 11-05-2025
- SUPV 11-24-2025
- Dividend Yield
- RGNX N/A
- SUPV 3.76%
- EPS Growth
- RGNX N/A
- SUPV N/A
- EPS
- RGNX N/A
- SUPV 0.09
- Revenue
- RGNX $155,782,000.00
- SUPV $631,132,570.00
- Revenue This Year
- RGNX $203.79
- SUPV $20.63
- Revenue Next Year
- RGNX $0.72
- SUPV $22.47
- P/E Ratio
- RGNX N/A
- SUPV $11.87
- Revenue Growth
- RGNX 74.95
- SUPV N/A
- 52 Week Low
- RGNX $5.04
- SUPV $4.54
- 52 Week High
- RGNX $12.28
- SUPV $19.75
- Technical
- Relative Strength Index (RSI)
- RGNX 76.74
- SUPV 42.27
- Support Level
- RGNX $10.24
- SUPV $4.74
- Resistance Level
- RGNX $11.00
- SUPV $5.16
- Average True Range (ATR)
- RGNX 0.63
- SUPV 0.46
- MACD
- RGNX 0.28
- SUPV 0.13
- Stochastic Oscillator
- RGNX 93.57
- SUPV 39.17
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About SUPV Grupo Supervielle S.A. each Representing five Class B shares
Grupo Supervielle SA offers financial products & services. The company's segments include Personal and Business Banking, Corporate Banking, Bank Treasury, Consumer Finance, Insurance, and Asset Management and other services. The company provides services to individuals, small businesses, middle-market companies, and large corporates in Argentina. The company also offers mutual fund services.